Clinical Trial Update: Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial compares Dotarem (gadoterate meglumine) with Gadovist (gadobutrol) for the diagnosis of peripheral arterial disease; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• Gadovist (gadobutrol)

Snippet

Sponsor: Guerbet | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-12-11